top of page
Mimetas partners with Attivare Therapeutics to accelerate innovation in cancer research
16 December 2025 Put in place to accelerate the development of innovative cancer therapies through collaboration initiatives, the Netherlands-based Oncode Accelerator program announces launching of its Demonstrator Project. Through this project, researchers and drug developers will be able to share expertise, experimental platforms, and infrastructure to advance novel therapeutic approaches. Recent advances in cancer therapies and in particular immunotherapy have produce
bottom of page
